Japanese Journal of Clinical Oncology 33:241-245 (2003)
© 2003 Foundation for Promotion of Cancer Research
Cancer Incidence and Incidence Rates in Japan in 1998: Estimates Based on Data from 12 Population-based Cancer Registries
,¶The Research Group for Population-based Cancer Registration in Japan estimated cancer incidence in Japan in 1998 based on data from 12 population-based cancer registries: Miyagi, Yamagata, Chiba, Kanagawa, Niigata, Fukui, Aichi, Shiga, Osaka, Hiroshima City, Saga and Nagasaki. The methods of estimation and its limitations are explained in previous papers (1–3). The number of incidences, crude rates, age-standardized rates and completeness of registration in 1998 are shown in Table 1 and the age-specific number of incidences and the rates are shown in Tables 2 and 3 according to sex and primary site. The number of incidences for 1998 was estimated as 504 000. The time trends of age-standardized incidence rates for major sites in 1975–98 standardized to the world population are shown in Fig. 1 and those standardized to the 1985 Japanese model population are shown in Fig. 2. The leading site in age-standardized incidence rate is stomach for males and breast for females in both Figures 1 and 2.
|
|
|
|
|
Estimated cancer incidence data in Japan by sex, site, five-year age group and calendar year during the period 1975–98 are now available on a Web site (http://www.mc.pref.osaka.jp/ocr/) or by correspondence with the principal investigator of the Research Group (Dr H. Tsukuma).
 |
ACKNOWLEDGMENTS |
|---|
 TOP ACKNOWLEDGMENTS REFERENCES |
|---|
In 2002 the Research Group conducted the 29th survey on cancer incidence and cancer medical care with the cooperation of the Aichi Cancer Center (Dr T. Kuroishi) and contributions from 14 cancer registries: Miyagi (Dr D. Shibuya), Yamagata (Dr T. Matsuda), Chiba (Dr H. Mikami), Kanagawa (Dr T. Nagaoka), Niigata (Dr K. Ogoshi), Fukui (Dr M. Fujita), Aichi (Dr M. Inoue, Dr K. Tajima), Shiga (Dr T. Imura), Osaka (Dr H. Tsukuma), Tottori (Dr T. Kishimoto), Hiroshima City (Dr K. Koyama), Saga (Dr K. Tanaka), Nagasaki (Dr M. Soda) and Okinawa (Dr S. Shimoji). The study was supported by a Grant-in-Aid for cancer research (14–2) from the Japanese Ministry of Health and Welfare.
|
FOOTNOTES |
|---|
+ This report was prepared by Wakiko Ajiki, Hideaki Tsukuma and Akira Oshima, Department of Cancer Control and Statistics, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
For reprints and all correspondence: Wakiko Ajiki, Department of Cancer Control and Statistics, Osaka Medical Center for Cancer and Cardiovascular Diseases, Nakamichi 1–3–3, Higashinari-ku, Osaka 537-8511, Japan. E-mail: ajiki-mi{at}umin.ac.jp
¶ Abbreviations: ICD-10th, International Classification of Diseases, 10th Revision; DCO/I, proportion of cases with the death certificate only to incident cases; I/D, number of incidence/number of deaths; HV/I, proportion of histologically verified cases to incident cases; CIS/carcinoma in situ
|
REFERENCES |
|---|
|
TOPACKNOWLEDGMENTSREFERENCES |
|---|
1 The Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1988: estimates based on data from 10 population-based cancer registries. Jpn J Clin Oncol 1994;24:299–304.
2 The Research Group for Population-based Cancer Registration in Japan. Cancer incidence in Japan, 1985–89: re-estimation based on data from eight population-based cancer registries. Jpn J Clin Oncol 1998;28:54–67.
3. The Research Group for Population-based Cancer Registration in Japan. Cancer incidence in Japan. In: Tominaga S and Oshima A, editors. Cancer Mortality and Morbidity Statistics Japan and the World – 1999. Monograph on Cancer Research No. 47. Tokyo: Japanese Scientific Societies Press 1999;83–143.
Received March 17, 2003; accepted April 10, 2003
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. DOI, M.-A. SHIBATA, E. SHIBATA, J. MORIMOTO, Y. AKAO, M. IINUMA, N. TANIGAWA, and Y. OTSUKI Panaxanthone Isolated from Pericarp of Garcinia mangostana L. Suppresses Tumor Growth and Metastasis of a Mouse Model of Mammary Cancer Anticancer Res, July 1, 2009; 29(7): 2485 - 2495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. W. Setiawan, C. A. Haiman, F. Z. Stanczyk, L. Le Marchand, and B. E. Henderson Racial/Ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1849 - 1855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tsukuma, W. Ajiki, A. Ioka, A. Oshima, and and Research Group of Population-Based Cancer Regi Survival of Cancer Patients Diagnosed between 1993 and 1996: a Collaborative Study of Population-Based Cancer Registries in Japan Jpn. J. Clin. Oncol., September 1, 2006; 36(9): 602 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kawaguchi, A. Matsumura, K. Iuchi, S. Ishikawa, H. Maeda, S. Fukai, H. Komatsu, and M. Kawahara Second Primary Cancers in Patients with Stage III Non-Small Cell Lung Cancer Successfully Treated with Chemo-radiotherapy Jpn. J. Clin. Oncol., January 1, 2006; 36(1): 7 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okamura, S. Yamawaki, T. Akechi, K. Taniguchi, and Y. Uchitomi Psychiatric Disorders Following First Breast Cancer Recurrence: Prevalence, Associated Factors and Relationship to Quality of Life Jpn. J. Clin. Oncol., June 1, 2005; 35(6): 302 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ioka, H. Tsukuma, W. Ajiki, and A. Oshima Trends in Head and Neck Cancer Incidence in Japan during 1965-1999 Jpn. J. Clin. Oncol., January 1, 2005; 35(1): 45 - 47. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||